Targeting S100p Sensitizes Pancreatic Cancer Cells towards Gemcitabine

被引：2
|
作者：
Tang, Shing Chun
Chen, Yangchao
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1158/1538-7445.PANCA16-A22
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A22
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Expression of S100A4, S100A6, and S100P in pancreatic and ampullary adenocarcinomas
    Lin, F.
    Hull, M. E.
    Shi, J.
    Prichard, J. W.
    Brown, R. E.
    Wang, H. L.
    Schuerch, C.
    LABORATORY INVESTIGATION, 2007, 87 : 286A - 286A
  • [32] Expression of S100A4, S100A6, and S100P in pancreatic and ampullary adenocarcinomas
    Lin, F.
    Hull, M. E.
    Shi, J.
    Prichard, J. W.
    Brown, R. E.
    Wang, H. L.
    Shuerch, C.
    MODERN PATHOLOGY, 2007, 20 : 286A - 286A
  • [33] Targeting Casein Kinase 1 Delta Sensitizes Pancreatic and Bladder Cancer Cells to Gemcitabine Treatment by Upregulating Deoxycytidine Kinase
    Vena, Francesca
    Bayle, Simon
    Nieto, Ainhoa
    Quereda, Victor
    Aceti, Massimiliano
    Frydman, Sylvia M.
    Sansil, Samer S.
    Grant, Wayne
    Monastyrskyi, Andrii
    McDonald, Patricia
    Roush, William R.
    Teng, Mingxiang
    Duckett, Derek
    MOLECULAR CANCER THERAPEUTICS, 2020, 19 (08) : 1623 - 1635
  • [34] S100P tumor-marker response to chemotherapy in patients with advanced pancreatic cancer.
    Mitsunaga, Shuichi
    Umemoto, Kumiko
    Watanabe, Kazuo
    Okuyama, Hiroyuki
    Hashimoto, Yusuke
    Takahashi, Hideaki
    Ohno, Izumi
    Shimizu, Satoshi
    Ochiai, Atsushi
    Ikeda, Masafumi
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [35] Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine
    Shimasaki, Takeo
    Ishigaki, Yasuhito
    Nakamura, Yuka
    Takata, Takanobu
    Nakaya, Naoki
    Nakajima, Hideo
    Sato, Itaru
    Zhao, Xia
    Kitano, Ayako
    Kawakami, Kazuyuki
    Tanaka, Takuji
    Takegami, Tsutomu
    Tomosugi, Naohisa
    Minamoto, Toshinari
    Motoo, Yoshiharu
    JOURNAL OF GASTROENTEROLOGY, 2012, 47 (03) : 321 - 333
  • [36] Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine
    Takeo Shimasaki
    Yasuhito Ishigaki
    Yuka Nakamura
    Takanobu Takata
    Naoki Nakaya
    Hideo Nakajima
    Itaru Sato
    Xia Zhao
    Ayako Kitano
    Kazuyuki Kawakami
    Takuji Tanaka
    Tsutomu Takegami
    Naohisa Tomosugi
    Toshinari Minamoto
    Yoshiharu Motoo
    Journal of Gastroenterology, 2012, 47 : 321 - 333
  • [37] Transcriptional regulation and functional implication of S100P in cancer
    Adriana Gibadulinova
    Veronika Tothova
    Jaromir Pastorek
    Silvia Pastorekova
    Amino Acids, 2011, 41 : 885 - 892
  • [38] S100P as a potential biomarker for immunosuppressive microenvironment in pancreatic cancer: a bioinformatics analysis and in vitro study
    Hao, Weiwei
    Zhang, Yanyan
    Dou, Jingwen
    Cui, Pu
    Zhu, Jicun
    BMC CANCER, 2023, 23 (01)
  • [39] S100P as a potential biomarker for immunosuppressive microenvironment in pancreatic cancer: a bioinformatics analysis and in vitro study
    Weiwei Hao
    Yanyan Zhang
    Jingwen Dou
    Pu Cui
    Jicun Zhu
    BMC Cancer, 23 (1)
  • [40] S100P antibody-mediated therapy as a new promising strategy for the treatment of pancreatic cancer
    S Dakhel
    L Padilla
    J Adan
    M Masa
    J M Martinez
    L Roque
    T Coll
    R Hervas
    C Calvis
    R Messeguer
    F Mitjans
    J L Hernández
    Oncogenesis, 2014, 3 : e92 - e92
12345